AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells
Authors:
Open Access
- 1 October 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (44) , 30045-30056
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 SitesCirculation Research, 2007
- Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor GeneCancer Research, 2007
- Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotypeBlood, 2005
- Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutationBlood, 2005
- RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiationBlood, 2003
- Differential Requirements for Runx Proteins in CD4 Repression and Epigenetic Silencing during T Lymphocyte DevelopmentCell, 2002
- In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesisBlood, 2002
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- Generation of Lymphohematopoietic Cells from Embryonic Stem Cells in CultureScience, 1994
- Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietinNature, 1994